cisplatin,gemcitabine,pembrolizumab,vibostolimab,nivolumab,favezelimab
bms,merck
['gusm', 'mibc', 'nmibc', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'cm274', 'kn057', 'hcrn,gu,16257', 'bladder']
day 2 #gu23 #bladdercancer highlights #communityoncology 1. #hcrngu16257: chemo+io in mibc 2. disparities in bladder ca 3. kn057 update: io in nmibc 4. current landscape by + 5. cm274 update #onced #gusm #medtwitter
Practice changing #Oncology news from #CommunityOncologists perspective w/ Rohit Gosain @UPMCHillmanCC & Rahul Gosain @WilmotCancer. Views are our own.